Can a community program cut the time to treat psychosis?
NCT ID NCT05813457
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a program called PRESTO that aims to identify and treat first-episode psychosis sooner. The program educates the public, trains frontline workers like doctors and teachers, and provides a mobile team to connect patients to care. Researchers will measure whether this reduces the time a person goes untreated, which may improve their long-term outlook. The trial involves 416 participants across multiple centers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PRESTO Early Identification Program (community education, training for frontline workers, and a mobile care team)
- What this could lead to
- If successful, this program could become a model for reducing delays in treating first-episode psychosis, potentially improving long-term outcomes for patients.
- What could go wrong
- This is a behavioral intervention study, not a drug trial. Results depend on community uptake and may not be easily replicated in other regions. The study is still recruiting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSYCHOTIC EPISODE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Montpellier
RECRUITINGMontpellier, 34090, France
-
CHU de Nîmes
RECRUITINGNîmes, 30900, France
-
Chu Clermont-Ferrand
RECRUITINGClermont-Ferrand, 63003, France
-
Chu Grenoble
RECRUITINGGrenoble, 38000, France
-
Chu Saint Etienne
RECRUITINGSaint-Etienne, 42100, France
-
Hospices Civils de Lyon
RECRUITINGBron, 69500, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill for schizophrenia pass its first human test?
- Can a new daily pill offer safer Long-Term control of schizophrenia?
- Can an Anti-Seizure drug quiet the brain and sharpen thinking in schizophrenia?
- Can a dissolving film tame agitation in schizophrenia?
- Can a phone app teach the brain to read social cues?
- Can a gentle brain current silence voices that medication Can't?